- SEK3.97bn
- SEK3.85bn
- SEK758.97m
Brief: Cellavision Q4 EBITDA Rises To SEK 41.5 Million
Brief: CellaVision Completes Acquisition Of RAL Diagnostics
Brief: Cellavision AB Says Co To Acquire RAL Diagnostics
Brief: CellaVision Q2 Operating Profit Up At SEK 112.4 Mln
Brief: CellaVision Jan-March Net Sales Rise To SEK 103.9 Million
Brief: Cellavision Q4 Operating Profit Up At SEK 35.8 Million
Brief: Grenlunden Increases Stake In Cellavision To 8.4 Pct Of Share Capital
Brief: CellaVision Q3 Operating Profit Up At SEK 21.0 Million
Brief: Cellavision AB Q2 Organic Growth Was 15%.
Brief: CellaVision Q1 Operating Profit Falls To SEK 23.2 Million
Brief: Cellavision AB Q4 Net Sales Up At Sek 76.1 Million
Brief: Cellavision Q3 operating profit falls to SEK 10.2 mln
Brief: Cellavision Q1 oper profit SEK 34.3 million
Brief: Cellavision prelim Q1 net sales over SEK 93 mln
Brief: Cellavision Q4 operating profit rises to SEK 21.6 mln
Brief: Cellavision Q3 operating profit falls to SEK 19.5 mln
Brief: CellaVision Q2 operating profit increases to SEK 19.1 mln
Brief: CellaVision Q1 operating profit rises to SEK 13.9 million
Brief: CellaVision Q4 operating profit down at SEK 16.4 million